<?xml version="1.0" encoding="utf-8"?> <rss version="2.0"> <channel xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/"> <title>Neptune Technologies & Bioressources Inc.</title> <link>https://www.globenewswire.com/rssfeed/organization/cVj95XvBS6aPtIk-oxFbcw==</link> <description>Contains the last 20 releases</description> <copyright>Copyright 2018, Neptune Technologies & Bioressources Inc.</copyright> <managingEditor>newsdesk@globenewswire.com (NewsDesk)</managingEditor> <lastBuildDate>Wed, 14 Feb 2018 21:30:22 GMT</lastBuildDate> <webMaster>webmaster@globenewswire.com (Webmaster)</webMaster> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/02/14/1448997/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-troisi%C3%A8me-trimestre.html</guid> <link>https://www.globenewswire.com/news-release/2018/02/14/1448997/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-troisi%C3%A8me-trimestre.html</link> <title>Neptune annonce ses résultats pour le troisième trimestre</title> <description><![CDATA[<p><em><p>Les activités du secteur du cannabis progressent comme prévu</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - 14 fév. 2018) -</strong> </p>]]></description> <pubDate>Wed, 14 Feb 2018 21:30 GMT</pubDate> <dc:identifier>1448997</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/02/14/1448996/0/en/Neptune-Announces-Third-Quarter-Results.html</guid> <link>https://www.globenewswire.com/news-release/2018/02/14/1448996/0/en/Neptune-Announces-Third-Quarter-Results.html</link> <title>Neptune Announces Third Quarter Results</title> <description><![CDATA[<p><em><p>Cannabis Business Development Underway and On Schedule</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - Feb. 14, 2018) -</strong> </p>]]></description> <pubDate>Wed, 14 Feb 2018 21:00 GMT</pubDate> <dc:identifier>1448996</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/02/12/1448995/0/fr/Neptune-et-Tetra-Bio-Pharma-concluent-une-entente-de-cod%C3%A9veloppement-de-produits-antidouleurs-et-anti-inflammatoires-%C3%A0-base-d-huiles-de-cannabino%C3%AFdes-purifi%C3%A9s.html</guid> <link>https://www.globenewswire.com/news-release/2018/02/12/1448995/0/fr/Neptune-et-Tetra-Bio-Pharma-concluent-une-entente-de-cod%C3%A9veloppement-de-produits-antidouleurs-et-anti-inflammatoires-%C3%A0-base-d-huiles-de-cannabino%C3%AFdes-purifi%C3%A9s.html</link> <title>Neptune et Tetra Bio-Pharma concluent une entente de codéveloppement de produits antidouleurs et anti-inflammatoires à base d'huiles de cannabinoïdes purifiés</title> <description><![CDATA[<p style="
 text-align:left;
 ">LAVAL, QUÉBEC--(Marketwired - 12 fév. 2018) - Neptune Technologies & Bioressources inc. (« Neptune ») (NASDAQ:NEPT)(TSX:NEPT) et Tetra Bio-Pharma Inc. (« Tetra ») (TSX CROISSANCE:TBP)(OTCQB:TBPMF) ont annoncé aujourd'hui la conclusion d'une entente de codéveloppement, de commercialisation et de mise en marché de produits à base d'huiles de cannabinoïdes purifiés contre la douleur et l'inflammation à l'intention des marchés des produits de santé naturelle et de la médecine vétérinaire.</p>]]></description> <pubDate>Mon, 12 Feb 2018 17:43 GMT</pubDate> <dc:identifier>1448995</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.;Tetra Bio-Pharma Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/02/12/1448994/0/en/Neptune-and-Tetra-Bio-Pharma-Enter-Co-Development-Agreement-for-Purified-Cannabinoid-Oil-Based-Products-targeting-Pain-and-Inflammation.html</guid> <link>https://www.globenewswire.com/news-release/2018/02/12/1448994/0/en/Neptune-and-Tetra-Bio-Pharma-Enter-Co-Development-Agreement-for-Purified-Cannabinoid-Oil-Based-Products-targeting-Pain-and-Inflammation.html</link> <title>Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Feb. 12, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ:NEPT)(TSX:NEPT) and Tetra Bio-Pharma Inc. ("Tetra") (TSX VENTURE:TBP)(OTCQB:TBPMF) today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.</p>]]></description> <pubDate>Mon, 12 Feb 2018 13:00 GMT</pubDate> <dc:identifier>1448994</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.;Tetra Bio-Pharma Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/01/31/1448992/0/en/Neptune-to-Hold-Conference-Call-to-Discuss-Third-Quarter-Results-for-the-Interim-Period-Ended-December-31-2017.html</guid> <link>https://www.globenewswire.com/news-release/2018/01/31/1448992/0/en/Neptune-to-Hold-Conference-Call-to-Discuss-Third-Quarter-Results-for-the-Interim-Period-Ended-December-31-2017.html</link> <title>Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Jan. 31, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT)(TSX:NEPT), announces that it will be holding a conference call on February 14, 2018 at 5:00 PM (EST) to discuss its third quarter results for the interim period ended December 31, 2017.</p>]]></description> <pubDate>Wed, 31 Jan 2018 13:00 GMT</pubDate> <dc:identifier>1448992</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/01/31/1448993/0/fr/Neptune-publiera-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-pour-la-p%C3%A9riode-interm%C3%A9diaire-termin%C3%A9e-le-31-d%C3%A9cembre-2017.html</guid> <link>https://www.globenewswire.com/news-release/2018/01/31/1448993/0/fr/Neptune-publiera-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-pour-la-p%C3%A9riode-interm%C3%A9diaire-termin%C3%A9e-le-31-d%C3%A9cembre-2017.html</link> <title>Neptune publiera ses résultats du troisième trimestre pour la période intermédiaire terminée le 31 décembre 2017</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 31 jan. 2018) -</strong> Neptune Technologies & Bioressources inc. (NASDAQ:NEPT)(TSX:NEPT) (« Neptune » ou « la Société »), annonce qu'elle tiendra une conférence téléphonique le 14 février 2018 à 17h00, heure normale de l'est, afin de commenter les résultats financiers du troisième trimestre pour la période intermédiaire terminée le 31 décembre 2017.</p>]]></description> <pubDate>Wed, 31 Jan 2018 13:00 GMT</pubDate> <dc:identifier>1448993</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/01/19/1315828/0/en/Neptune-Announces-Research-Agreement-Aimed-at-New-Medical-and-Wellness-Cannabinoid-based-Products.html</guid> <link>https://www.globenewswire.com/news-release/2018/01/19/1315828/0/en/Neptune-Announces-Research-Agreement-Aimed-at-New-Medical-and-Wellness-Cannabinoid-based-Products.html</link> <title>Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Jan. 19, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ:NEPT)(TSX:NEPT) today announced an exclusive research agreement with the purpose of developing new medical and wellness targeted cannabinoid-based products, such as cannabidiol ("CBD"), combined with krill oil whose combination use would be exclusive to Neptune. The new products will be aimed at the growing number of federal jurisdictions worldwide that have or will legalize cannabinoids, such as Canada, for medicinal and/or adult use. </p>]]></description> <pubDate>Fri, 19 Jan 2018 13:00 GMT</pubDate> <dc:identifier>1315828</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/01/19/1315831/0/fr/Neptune-annonce-une-entente-de-recherche-visant-%C3%A0-d%C3%A9velopper-de-nouveaux-produits-de-sant%C3%A9-et-de-mieux-%C3%AAtre-%C3%A0-base-de-cannabino%C3%AFdes.html</guid> <link>https://www.globenewswire.com/news-release/2018/01/19/1315831/0/fr/Neptune-annonce-une-entente-de-recherche-visant-%C3%A0-d%C3%A9velopper-de-nouveaux-produits-de-sant%C3%A9-et-de-mieux-%C3%AAtre-%C3%A0-base-de-cannabino%C3%AFdes.html</link> <title>Neptune annonce une entente de recherche visant à développer de nouveaux produits de santé et de mieux-être à base de cannabinoïdes</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 19 jan. 2018) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) a annoncé aujourd'hui une entente de recherche exclusive ayant pour but de mettre au point de nouveaux produits de santé et de mieux-être à base de cannabinoïdes, comme le cannabidiol (CBD), qui contiendront également de l'huile de krill dont l'utilisation combinée serait exclusive à Neptune. Le marché visé est le nombre toujours croissant des juridictions fédérales à travers le monde qui ont ou auront légalisé la consommation de produits du cannabis par les adultes ou à des fins médicales, dont le Canada.</p>]]></description> <pubDate>Fri, 19 Jan 2018 13:00 GMT</pubDate> <dc:identifier>1315831</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/01/17/1315825/0/en/Neptune-makes-its-recommendations-on-Bill-157-special-consultations-at-the-National-Assembly.html</guid> <link>https://www.globenewswire.com/news-release/2018/01/17/1315825/0/en/Neptune-makes-its-recommendations-on-Bill-157-special-consultations-at-the-National-Assembly.html</link> <title>Neptune makes its recommendations on Bill 157 special consultations at the National Assembly</title> <description><![CDATA[<p><em><p>A Quebec company with unique expertise in oil extraction has global objectives for cannabis</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - Jan. 17, 2018) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ:NEPT)(TSX:NEPT) is pleased to announce that it will participate in special consultations on Bill 157, regulating cannabis. Michel Timperio, President of the Cannabis Business division at Neptune, will make a presentation on Wednesday, January 17, 2018, at 2:00 p.m., and will table a submission to the Committee on Health and Social Services of the National Assembly in Québec. It will be possible to listen to the presentation live at <a rel="nofollow" href="http://www.assnat.qc.ca/en/video-audio/en-direct-webdiffusion.html" title="">http://www.assnat.qc.ca/en/video-audio/en-direct-webdiffusion.html</a>. (in French only).</p>]]></description> <pubDate>Wed, 17 Jan 2018 13:00 GMT</pubDate> <dc:identifier>1315825</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/01/17/1315827/0/fr/Neptune-pr%C3%A9sente-ses-recommandations-aux-consultations-particuli%C3%A8res-sur-le-projet-de-loi-157-%C3%A0-l-Assembl%C3%A9e-nationale.html</guid> <link>https://www.globenewswire.com/news-release/2018/01/17/1315827/0/fr/Neptune-pr%C3%A9sente-ses-recommandations-aux-consultations-particuli%C3%A8res-sur-le-projet-de-loi-157-%C3%A0-l-Assembl%C3%A9e-nationale.html</link> <title>Neptune présente ses recommandations aux consultations particulières sur le projet de loi 157 à l'Assemblée nationale</title> <description><![CDATA[<p><em><p>Une entreprise québécoise à l'expertise unique dans l'extraction d'huile a des visées mondiales en matière de cannabis</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - 17 jan. 2018) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) est heureuse d'annoncer qu'elle participera aux consultations particulières sur le projet de loi 157 encadrant le cannabis. À cet effet, M. Michel Timperio, président de la division Cannabis chez Neptune, effectuera une présentation ce mercredi le 17 janvier 2018 à 14 h 00 et déposera un mémoire à la Commission sur la santé et les services sociaux de l'Assemblée nationale, à Québec. Il sera possible d'écouter la présentation en direct à : <a rel="nofollow" href="http://www.assnat.qc.ca/fr/video-audio/en-direct-webdiffusion.html" title="">http://www.assnat.qc.ca/fr/video-audio/en-direct-webdiffusion.html</a>.</p>]]></description> <pubDate>Wed, 17 Jan 2018 13:00 GMT</pubDate> <dc:identifier>1315827</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/12/11/1315820/0/en/Strength-Sensei-Nutraceuticals-and-Charles-R-Poliquin-launch-MaxSimil.html</guid> <link>https://www.globenewswire.com/news-release/2017/12/11/1315820/0/en/Strength-Sensei-Nutraceuticals-and-Charles-R-Poliquin-launch-MaxSimil.html</link> <title>Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Dec. 11, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT)(TSX:NEPT) announces, in partnership with Charles R. Poliquin's Strength Sensei Nutraceuticals, the launch of MaxSimil® enhanced Omega Drive™ omega-3 EPA and DHA product for the strength coaching community.</p>]]></description> <pubDate>Mon, 11 Dec 2017 13:30 GMT</pubDate> <dc:identifier>1315820</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/12/11/1315822/0/fr/Strength-Sensei-Nutraceuticals-et-Charles-R-Poliquin-lancent-MaxSimil.html</guid> <link>https://www.globenewswire.com/news-release/2017/12/11/1315822/0/fr/Strength-Sensei-Nutraceuticals-et-Charles-R-Poliquin-lancent-MaxSimil.html</link> <title>Strength Sensei Nutraceuticals et Charles R. Poliquin lancent MaxSimil®</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 11 déc. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce, en partenariat avec Strength Sensei Nutraceuticals, une entreprise de Charles R. Poliquin, le lancement d'Omega Drive<sup>MC</sup>, un produit contenant de l'AEP et de l'ADH, deux acides gras oméga-3, et qui, enrichi de MaxSimil®, se destine au milieu de la préparation physique.</p>]]></description> <pubDate>Mon, 11 Dec 2017 13:30 GMT</pubDate> <dc:identifier>1315822</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/30/1315816/0/en/Neptune-Receives-Nasdaq-Notification-Confirming-that-it-has-Regained-Compliance-with-Minimum-Bid-Requirements.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/30/1315816/0/en/Neptune-Receives-Nasdaq-Notification-Confirming-that-it-has-Regained-Compliance-with-Minimum-Bid-Requirements.html</link> <title>Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 30, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), announces that on November 28, 2017 it received notification from Nasdaq Listing Qualifications Department confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) - bid price. </p>]]></description> <pubDate>Thu, 30 Nov 2017 13:00 GMT</pubDate> <dc:identifier>1315816</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/30/1315818/0/fr/Neptune-re%C3%A7oit-un-avis-de-Nasdaq-confirmant-qu-elle-est-de-nouveau-conforme-%C3%A0-l-exigence-relative-au-cours-acheteur-minimum.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/30/1315818/0/fr/Neptune-re%C3%A7oit-un-avis-de-Nasdaq-confirmant-qu-elle-est-de-nouveau-conforme-%C3%A0-l-exigence-relative-au-cours-acheteur-minimum.html</link> <title>Neptune reçoit un avis de Nasdaq confirmant qu'elle est de nouveau conforme à l'exigence relative au cours acheteur minimum</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 30 nov. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce qu'elle a reçu, le 28 novembre 2017, un avis du service d'admissibilité à la cote de NASDAQ confirmant que la Société est de nouveau conforme à l'exigence de la règle d'inscription à la cote 5550(a)(2) de NASDAQ sur le cours acheteur.</p>]]></description> <pubDate>Thu, 30 Nov 2017 13:00 GMT</pubDate> <dc:identifier>1315818</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/28/1315812/0/en/Highlights-of-Neptune-s-Investor-Conference-Being-Held-in-New-York-Today.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/28/1315812/0/en/Highlights-of-Neptune-s-Investor-Conference-Being-Held-in-New-York-Today.html</link> <title>Highlights of Neptune's Investor Conference Being Held in New York Today</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 28, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune Wellness" or the "Company") (NASDAQ:NEPT)(TSX:NEPT), is holding its Investor Conference in New York City to present its "Cannabis Business Roadmap". Management presentations will start at 8.00 a.m. EST and investors will have access to a webcast as well as a presentation via the Company's web site (see information below). </p>]]></description> <pubDate>Tue, 28 Nov 2017 12:00 GMT</pubDate> <dc:identifier>1315812</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/28/1315814/0/fr/Aper%C3%A7u-de-la-conf%C3%A9rence-de-Neptune-%C3%A0-l-intention-de-ses-investisseurs-qui-se-tient-aujourd-hui-%C3%A0-New-York.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/28/1315814/0/fr/Aper%C3%A7u-de-la-conf%C3%A9rence-de-Neptune-%C3%A0-l-intention-de-ses-investisseurs-qui-se-tient-aujourd-hui-%C3%A0-New-York.html</link> <title>Aperçu de la conférence de Neptune à l'intention de ses investisseurs, qui se tient aujourd'hui à New York</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 28 nov. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) dévoilera à ses investisseurs, lors d'une conférence à New York, sa stratégie <em>Le plan d'affaires vers le cannabis.</em> Les présentations de la haute direction commenceront à 8h00 (HNE). Les investisseurs auront accès à la conférence au moyen d'une webdiffusion, ainsi qu'à une présentation via le site Web de la Société (voir les renseignements ci-dessous).</p>]]></description> <pubDate>Tue, 28 Nov 2017 12:00 GMT</pubDate> <dc:identifier>1315814</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/27/1315809/0/en/Neptune-Extends-Global-MaxSimil-Licence-To-Cannabis-Derived-Products.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/27/1315809/0/en/Neptune-Extends-Global-MaxSimil-Licence-To-Cannabis-Derived-Products.html</link> <title>Neptune Extends Global MaxSimil® Licence To Cannabis-Derived Products</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 27, 2017) -</strong> Neptune Technologies & Bioressources Inc. ("Neptune Wellness" or the "Company") (NASDAQ:NEPT)(TSX:NEPT), today announced an exclusive, worldwide and royalty bearing licensing agreement for the use of the MaxSimil<strong>® </strong>technology, a patented omega-3 fatty acid delivery technology and strong growth driver of Neptune's Solutions business, in combination with cannabis-derived products.</p>]]></description> <pubDate>Mon, 27 Nov 2017 13:00 GMT</pubDate> <dc:identifier>1315809</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/27/1315811/0/fr/Neptune-%C3%A9tend-la-port%C3%A9e-de-sa-licence-mondiale-sur-MaxSimil-aux-produits-d%C3%A9riv%C3%A9s-du-cannabis.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/27/1315811/0/fr/Neptune-%C3%A9tend-la-port%C3%A9e-de-sa-licence-mondiale-sur-MaxSimil-aux-produits-d%C3%A9riv%C3%A9s-du-cannabis.html</link> <title>Neptune étend la portée de sa licence mondiale sur MaxSimil® aux produits dérivés du cannabis</title> <description><![CDATA[<p><strong>LAVAL, QUÉBEC--(Marketwired - 27 nov. 2017) -</strong> Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) a annoncé aujourd'hui la signature d'un accord de licence mondiale exclusive assortie de redevances visant l'utilisation de la technologie MaxSimil®, une technologie brevetée d'optimisation de l'absorption des acides gras oméga-3 et un important moteur de croissance pour les solutions d'entreprise de Neptune, en combinaison avec des produits dérivés du cannabis.</p>]]></description> <pubDate>Mon, 27 Nov 2017 13:00 GMT</pubDate> <dc:identifier>1315811</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/14/1315804/0/en/Neptune-Announces-Second-Quarter-Results.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/14/1315804/0/en/Neptune-Announces-Second-Quarter-Results.html</link> <title>Neptune Announces Second Quarter Results</title> <description><![CDATA[<p><em><p>Cannabis Business Moves Forward with the Approval of $5M Investment</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - Nov. 14, 2017) -</strong> </p>]]></description> <pubDate>Tue, 14 Nov 2017 21:05 GMT</pubDate> <dc:identifier>1315804</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources Inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2017/11/14/1315807/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-deuxi%C3%A8me-trimestre.html</guid> <link>https://www.globenewswire.com/news-release/2017/11/14/1315807/0/fr/Neptune-annonce-ses-r%C3%A9sultats-pour-le-deuxi%C3%A8me-trimestre.html</link> <title>Neptune annonce ses résultats pour le deuxième trimestre</title> <description><![CDATA[<p><em><p>La Société va de l'avant dans le marché du cannabis avec l'approbation d'un investissement de 5 millions de dollars</p></em></p><p><strong>LAVAL, QUÉBEC--(Marketwired - 14 nov. 2017) -</strong> </p>]]></description> <pubDate>Tue, 14 Nov 2017 21:05 GMT</pubDate> <dc:identifier>1315807</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Neptune Technologies & Bioressources inc.</dc:contributor> <dc:modified>Sun, 22 Apr 2018 02:54 GMT</dc:modified> </item> </channel> </rss>